Dyspepsia Clinical Trial
Official title:
Advancing Nutritional Science for Children With Functional Dyspepsia
NCT number | NCT04053049 |
Other study ID # | H-44307 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2019 |
Est. completion date | December 1, 2021 |
Verified date | March 2022 |
Source | Baylor College of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates four different meals and how they induce gastrointestinal symptoms in children with functional dyspepsia. All subjects will receive each meal and rate their gastrointestinal symptoms during each meal.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 1, 2021 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 10 Years to 17 Years |
Eligibility | Inclusion Criteria: - Rome IV Functional Dyspepsia with post-prandial distress - Previously completed normal upper endoscopy with duodenal biopsies and/or previously completed a gastric emptying scintigraphy study Exclusion Criteria: - Previous abdominal surgery - Current or previous formal psychiatric diagnosis (e.g. anxiety disorder) requiring therapy or psychotropics - Serious chronic medical condition requiring regular medical care - Allergy to meal components to be ingested during the study - On specialized diet required for a medical condition - Pregnancy - Inability to eat by mouth |
Country | Name | City | State |
---|---|---|---|
United States | Children's Nutrition Research Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
Baylor College of Medicine | NASPGHAN Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dyspepsia Symptom Severity | Change from baseline gastrointestinal symptoms using total visual analogue scale score | up to 16 weeks | |
Secondary | Dyspepsia Symptom Onset | Time to maximum symptom severity | up to 16 weeks | |
Secondary | Duodenal inflammation | Previously obtained duodenal mucosal biopsies will be re-evaluated for eosinophils and mast cells | up to 16 weeks | |
Secondary | Gastric retention | Gastric retention values will be captured from a previously completed 4-hour gastric emptying scintigraphy study | up to 16 weeks | |
Secondary | Psychosocial distress | Anxiety, Depression, and Somatization will be determined using Behavioral Assessment for Children-3 (t-scores for anxiety and depression) and Children's Somatization Inventory Score (total score). | up to 16 weeks | |
Secondary | Gastric accommodation | Gastric accommodation will be determined from a previously completed 4-hour gastric scintigraphy study using analysis of the time zero image. | up to 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06094062 -
Smartphone App-assisted PPI
|
N/A | |
Completed |
NCT03941288 -
Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
|
Phase 2 | |
Completed |
NCT04429802 -
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
|
N/A | |
Not yet recruiting |
NCT06369753 -
Visible Abdominal Distension
|
N/A | |
Withdrawn |
NCT02863822 -
Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.
|
N/A | |
Recruiting |
NCT00978159 -
Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
|
Phase 4 | |
Completed |
NCT00723502 -
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
|
Phase 2 | |
Terminated |
NCT00220844 -
Tricyclic Antidepressants (TCAs) on Gastric Emptying
|
N/A | |
Completed |
NCT00148603 -
Montelukast in the Treatment of Duodenal Eosinophilia
|
N/A | |
Completed |
NCT00217347 -
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
|
N/A | |
Completed |
NCT00232102 -
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
|
Phase 3 | |
Completed |
NCT00164996 -
Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patient With or Without Local Pharyngeal Anaesthesia
|
Phase 3 | |
Completed |
NCT00110968 -
Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
|
Phase 3 | |
Completed |
NCT00232037 -
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia
|
Phase 3 | |
Recruiting |
NCT05718960 -
Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
|
N/A | |
Terminated |
NCT04247100 -
A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders
|
N/A | |
Completed |
NCT05750641 -
The Efficacy of Removal of Animal Milk From the Diet in Functional Dyspepsia: A Cross-sectional Study
|
||
Completed |
NCT04697641 -
Helicobacter Pylori Eradication in Functional Dyspepsia
|
N/A | |
Completed |
NCT03252743 -
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
|
N/A | |
Recruiting |
NCT04918329 -
Functional Digestive Disorders Observatory
|